Thrombospondin Plays a Vital Role in the Immune Privilege of the Eye

REFERENCES

• Streilein J W. Immunoregulatory mechanisms of the eye. Prog Retin Eye Res. 1999; 18: 357–470
   PubMed Web of Science ®Google Scholar
• Streilein J W, Dana M R, Ksander B R. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today 1997; 8: 443–449
   Google Scholar
• Ishida K, Panjwani N, Cao Z, et al. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T cell activation by partially non-overlapping mechanisms. Ocul Immunol Inflam. 2003; 11: 9–105
   Google Scholar
• Sugita S, Streilein J W. Iris pigment epithelium expressing CD86 (B7–2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2003; 198: 161–171
   PubMed Web of Science ®Google Scholar
• Holtkamp G M, Kijlstra A, Peek R, et al. RPE-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res. 2001; 20: 29–48
   PubMed Web of Science ®Google Scholar
• Wenkel H, Streilein J W. Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest Ophthalmol Vis Sci. 1998; 39: 1823–1834
   PubMed Web of Science ®Google Scholar
• Fröhlich E, Klessen C. Enzymatic heterogeneity of bovine retinal pigment epithelial cells in vivo and in vitro. Graefes Arch Clin Exp Ophthalmol. 2001; 239: 25–34
   PubMedGoogle Scholar
• Gundersen D, Powell S K, Rodriguez-Boulan E. Apical polarization of N-CAM in RPE is dependent on contact with the neural retina. J Cell Biol. 1993; 121: 335–343
   PubMedGoogle Scholar
• Yao X Y, Hageman G S, Marmor M F. Recovery of retinal adhesion after enzymatic perturbation of the interphotoreceptor matrix. Invest Ophthalmol Vis Sci. 1992; 33: 498–503
   PubMedGoogle Scholar
• Shimonkevitz R, Colon S, Kappler J W, et al. Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J Immunol. 1984; 133: 2067–2074
   PubMed Web of Science ®Google Scholar
• Namba K, Kitaichi N, Nishida T, et al. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and TGF-β2. J Leukoc Biol. 2002; 72: 946–952
   PubMed Web of Science ®Google Scholar
• Whiteley S J, Klassen H, Coffey P J, et al. Photoreceptor rescue after low-dose intravitreal IL-1beta injection in the RCS rat. Exp Eye Res. 2001; 73: 557–568
   PubMedGoogle Scholar
• Jiang L Q, Jorquera M, Streilein J W. Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts. Exp Eye Res. 1994; 58: 719–728
   PubMed Web of Science ®Google Scholar
• Avichezer D, Silver P B, Chan C C, et al. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest Ophthalmol Vis Sci. 2000; 41: 127–131
   PubMedGoogle Scholar
• Taylor A W, Ye D G, Nishida T, et al. Neuropeptide regulation of immunity: the immunosuppressive activity of alpha-melanocyte- stimulating hormone (alpha-MSH). Ann NY Acad Sci. 2000; 917: 239–247
   PubMedGoogle Scholar
• Tanihara H, Yoshida M, Matsumoto M, Yoshimura N. Identification TGF-β expressed in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1993; 34: 413–419
   PubMed Web of Science ®Google Scholar
• Cousins S W, McCabe M M, Danielpour D, et al. Identification of TGF-β as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991; 32: 2201–2211
   PubMed Web of Science ®Google Scholar
• Lucas P J, Kim S J, Melby S J, et al. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative TGF-β II receptor. J Exp Med. 2000; 191: 1187–1196
   PubMed Web of Science ®Google Scholar
• Crawford S E, Stellmach V, Murphy-Ullrich J E, et al. TSP-1 is a major activator of TGF-β1 in vivo. Cell. 1998; 93: 1159–1170
   PubMed Web of Science ®Google Scholar
• Carron J A, Hiscott P, Hagan S, et al. Cultured human RPE cells differentially express TSP-1, -2, -3, and -4. Int J Biochem Cell Biol. 2000; 32: 1137–1142
   PubMedGoogle Scholar
• Miyajima-Uchida H, Hayashi H, Beppu R, et al. Production and accumulation of TSP-1 in human RPE cells. Invest Ophthalmol Vis Sci. 2000; 41: 561–567
   PubMed Web of Science ®Google Scholar
• Avice M N, Rubio M, Sergerie M, et al. CD47 ligation selectively inhibits the development of human naïve T cells into Th1 effectors. J Immunol. 2000; 165: 4624–4631
   PubMedGoogle Scholar
• Saoudi A, Kuhn J, Huygen K, et al. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol. 1993; 23: 3096–3103
   PubMed Web of Science ®Google Scholar
• Liversidge J, McKay D, Mullen G, et al. RPE cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol. 1993; 149: 315–330
   PubMed Web of Science ®Google Scholar
• Rezai K A, Semnani R T, Farrokh-Siar L, et al. Human fetal RPE cells induce apoptosis in allogenic T-cells in a Fas ligand and PGE2 independent pathway. Curr Eye Res. 1999; 18: 430–439
   PubMed Web of Science ®Google Scholar
• Lyons R M, Gentry L E, Purchio A F, et al. Mechanism of activation of latent recombinant TGF-β1 by plasmin. J Cell Biol. 1990; 110: 1361–1367
   PubMed Web of Science ®Google Scholar
• Murphy-Ullrich J E, Poczatek M. Activation of latent TGF-β by TSP-1: mechanisms and physiology. Cytokine Growth Factor Rev. 2000; 11: 59–69
   PubMed Web of Science ®Google Scholar
• Siren V, Stephens R W, Salonen E MA, et al. RPE cells secrete urokinase-type plasminogen activator and its inhibitor PAI-1. Ophthalmic Res. 1992; 24: 203–212
   PubMed Web of Science ®Google Scholar
• Elner S G. Human RPE lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase. Trans Am Ophthalmol Soc. 2002; 100: 273–299
   PubMedGoogle Scholar
• Hara Y, Caspi R R, Wiggert B, et al. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis. Curr Eye Res 1992; 11: 97–100, (suppl)
   PubMed Web of Science ®Google Scholar
• Tolsma S S, Volpert O V, Good D J, et al. Peptides derived from two separate domains of the matrix protein TSP-1 have anti-angiogenic activity. J Cell Biol. 1993; 122: 497–511
   PubMed Web of Science ®Google Scholar
• Bleuel K, Popp S, Fusenig N E, et al. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or TSP-1 overexpression through halted tumor vascularization. Proc Natl Acad Sci USA 1999; 96: 2065–2070
   PubMed Web of Science ®Google Scholar
• Schultz-Cherry S, Chen H, Mosher D F, et al. Regulation of TGF-β activation by discrete sequences of TSP-1. J Biol Chem. 1995; 270: 7304–7310
   PubMed Web of Science ®Google Scholar
• Dawson D W, Pearce S F, Zhong R, et al. CD36 mediates the in vitro inhibitory effects of TSP-1 on endothelial cells. J Cell Biol. 1997; 138: 707–717
   PubMed Web of Science ®Google Scholar
• Guo N H, Krutzsch H C, Negre E, et al. Heparin-binding peptides from the type I repeats of TSP: structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis. J Biol Chem. 1992; 267: 19349–19355
   PubMedGoogle Scholar